Algert Global LLC Biolife Solutions Inc Transaction History

Algert Global LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$17.67 - $26.07 $562,665 - $830,147	-31,843 Reduced 55.91%	25,116 $546,000
Q4 2022 Feb 13, 2023	SELL	$16.95 - $25.07 $163,753 - $242,201	-9,661 Reduced 14.5%	56,959 $1.04 Million
Q3 2022 Nov 15, 2022	SELL	$14.64 - $26.7 $505,387 - $921,710	-34,521 Reduced 34.13%	66,620 $1.52 Million
Q2 2022 Aug 15, 2022	BUY	$10.54 - $24.2 $1.07 Million - $2.45 Million	101,141 New	101,141 $1.4 Million
Q1 2022 May 16, 2022	SELL	$20.81 - $37.29 $252,841 - $453,073	-12,150 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$32.99 - $58.55 $400,828 - $711,382	12,150 New	12,150 $453,000

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.16B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.